Exploring Best Practices for Diagnosis and Management of Hypereosinophilic Syndrome

To participate in this activity, please:

Hypereosinophilic syndromes (HESs) are a broad group of disorders that can lead to serious complications, including cardiovascular disease, cerebrovascular disease, and death. Due to their rarity, however, HESs are challenging to diagnose and treat. In this in-depth review, presented by Princess Ogbogu, MD, and developed in collaboration with Michael Wechsler, MD, MMSc, the wide-ranging presentations of HES will be reviewed, along with pathophysiology, classification, and acute and chronic management. Learnings from the presentation will be tied together with a case-based presentation of idiopathic HES, allowing learners to see how guideline recommendations and novel clinical trials can be applied in a real clinical setting.

This program is also available as a podcast.  You may download it here: https://anchor.fm/hypereosinophilicsyndrome 

Course Credit:

1 ACPE Contact Hour
1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
1 CA-BRN Contact Hour


Opens: 2021-06-30
Closes: 2022-06-30

Target Audience:

This activity is intended for allergists, immunologists, pulmonologists, along with other specialists and clinicians involved in the diagnosis and management of patients with hypereosinophilic syndrome.

This educational activity is supported by an educational grant from GlaxoSmithKline.

    Presenting Faculty

  • Princess Ogbogu, MD

    Chief of the Division of Allergy, Immunology, and Rheumatology
    University Hospitals Rainbow Babies & Children’s Hospital
    Cleveland, Ohio

  • Michael E. Wechsler, MD, MMSc

    Professor of Medicine
    Director, Cohen Family NJH Asthma Institute
    Director, Asthma Program, National Jewish Health
    Division of Pulmonary, Critical Care and Sleep Medicine
    Department of Medicine
    National Jewish Health and University of Colorado School of Medicine
    Denver, Colorado